After several years of robust expansion, the leading branded pharma companies will see growth slow to just 1.3% from now to 2015, independent market analyst company Datamonitor said in a new report. The primary culprit: expirin…
Shares of Novartis soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon for $12.9 billion.
Continue reading Novartis Obtains Final Shares of Alcon fo…
As the Anglo-Swedish drugmaker looks to divest assets, it seeks a buyer for its dental implants and medical devices unit Astra Tech.
Continue reading AstraZeneca Looking to Sell Unit for $2 Billion
…